Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections
Background. Transplanting hepatitis C viremic donor organs into hepatitis C virus (HCV)-negative recipients is becoming increasingly common; however, practices for posttransplant direct-acting antiviral (DAA) treatment vary widely. Protracted insurance authorization processes for DAA therapy often l...
Sparad:
| Huvudupphov: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Wolters Kluwer
2021-10-01
|
| Serie: | Transplantation Direct |
| Länkar: | http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001222 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|
